Instrument Fundamentals
| Date | Close | Change | Change (%) | Open | High | Low |
|---|
News
Best Dividend Stocks To Follow Today - December 15th - Markets Daily
Promising Pharmaceutical Stocks To Watch Now - December 15th - Markets Daily
Watts Gwilliam & Co. LLC Buys 50,744 Shares of Pfizer Inc. $PFE
Bank of America Lowers Pfizer (NYSE:PFE) Price Target to $28.00
ANALYSIS: Novo's Novel GLP-1 Bid Failed But That's Not the Point
MASTERINVEST Kapitalanlage GmbH Makes New Investment in Pfizer Inc. $PFE - Markets Daily
47,996 Shares in Pfizer Inc. $PFE Acquired by MASTERINVEST Kapitalanlage GmbH
FDA approves Pfizer's RSV vaccine for pregnant women amid safety concerns and growing vaccine debate - NaturalNews.com
Pfizer Inc. $PFE Shares Sold by SevenBridge Financial Group LLC - Stock Observer
Watts Gwilliam & Co. LLC Has $1.92 Million Stock Holdings in Pfizer Inc. $PFE - Daily Political
Top Dividend Stocks To Follow Now - December 14th - Markets Daily
Should You Forget Teva Pharmaceutical and Buy These Unstoppable Stocks Instead?
MRP Capital Investments LLC Has $494,000 Stock Holdings in Pfizer Inc. $PFE - Markets Daily
Beddow Capital Management Inc. Cuts Stock Holdings in Pfizer Inc. $PFE
Banque Transatlantique SA Lowers Stake in Pfizer Inc. $PFE
Bellevue Group AG Reduces Holdings in Pfizer Inc. $PFE - Markets Daily
Pfizer Inc. $PFE Shares Purchased by Adage Capital Partners GP L.L.C.
Real-world effectiveness of PARP inhibitors after CDK4/6 inhibitor therapy in BRCA-mutated HR-positive/HER2-negative advanced breast cancer
Clinical outcome and proportion of hereditary cancer genes gPV in TNBC: the HEaRTBeat study
Dividend Stocks To Follow Now - December 12th - Markets Daily
Healthy Returns: FDA may add strongest safety warning to Covid shots
Pfizer Stock (PFE) Gets Cautious 2026 Call from Morgan Stanley - Here's Why | Markets Insider
Pfizer Inc. $PFE Shares Sold by Camber Capital Management LP - Markets Daily
FDA intends to put its most serious warning on Covid vaccines, sources say | CNN
Camber Capital Management LP Has $36.36 Million Stock Holdings in Pfizer Inc. $PFE - Stock Observer
RFK Jr.'s Former Group Urges FDA to Revoke COVID Vax Licenses | MedPage Today
Why AbbVie, Pfizer and Medtronic appeal to dividend investors
Democratic Senators Demand Details on Trump's Drugmaker Deals
Pharma deal a near-total victory for industry lobbying effort
Town Health donates Pfizer pneumococcal vaccines PCV20, as chair Karson Choi urges seniors to get vaccinated
Top Pharmaceutical Stocks To Keep An Eye On - December 11th - Daily Political
Pfizer Inc. (PFE) Announces Results from Phase 3 BASIS Study
Will Obesity Bet and TUKYSA Data Shift Pfizer's (PFE) Post-COVID Growth Narrative?
Pfizer Inc. $PFE Shares Sold by Marshall Wace LLP
How the Narrative Surrounding Pfizer Is Changing After Obesity Deals and Sector Rerating
Pfizer Inc. $PFE Shares Sold by Schwerin Boyle Capital Management Inc. - Daily Political
FDA investigating possible adult deaths from COVID vaccines - San Diego Union-Tribune
Pfizer (NYSE:PFE) Trading Up 1.7% - Here's Why - Stock Observer
'Misbranded': Petition urges delicensing of COVID shots over failure to comply with rules * WorldNetDaily * by Bob Unruh
Pfizer layoffs: Pharma giant to cut hundreds of jobs in this country to reduce costs
Pfizer to cut over 200 jobs in Switzerland to reduce costs, Bloomberg News reports
Pfizer Inc. (PFE) Announces Results from the Phase 3 BASIS Study Evaluating HYMPAVZI
Fosun"s Yao Pharma, Pfizer sign exclusive collaboration deal
Pfizer Inc. $PFE Shares Sold by Lombard Odier Asset Management Switzerland SA
Pfizer Inc. $PFE Shares Bought by Daiwa Securities Group Inc. - Markets Daily
Axa S.A. Raises Stock Holdings in Pfizer Inc. $PFE
Arrow Capital Pty Ltd Acquires New Shares in Pfizer Inc. $PFE
Lombard Odier Asset Management Switzerland SA Cuts Holdings in Pfizer Inc. $PFE - Stock Observer
China's Fosun Pharma unit strikes US$2.1 billion obesity drug deal with Pfizer | South China Morning Post
Pfizer Weight-loss Pill: Pfizer to License YaoPharma's $2 Billion Weight-Loss Pill YP05002, ETPharma
Pfizer (NYSE:PFE) Stock Price Down 1.6% - Should You Sell?
Pfizer signs license deal with Fosun unit for obesity drug
Pfizer strikes deal with YaoPharma for obesity pill
State Street Corp Cuts Holdings in Pfizer Inc. $PFE
Paradigm Capital Management LLC NV Sells 21,686 Shares of Pfizer Inc. $PFE - Markets Daily
Augments Pfizer's efforts to advance investigational medicin
Pfizer Inc. $PFE Shares Sold by Gabelli Funds LLC
Pfizer adds heft to obesity pipeline in $2B Yaopharma deal | BioWorld
2 Companies Poised to Capitalize on the Rise of GLP-1 Drugs
The Dangers of Denying All Vaccine-Related Deaths - The Atlantic
SVB Wealth LLC Invests $4.07 Million in Pfizer Inc. $PFE
Natixis Has $45.97 Million Stock Holdings in Pfizer Inc. $PFE
Ossiam Boosts Stock Position in Pfizer Inc. $PFE
Gamco Investors INC. ET AL Trims Stock Holdings in Pfizer Inc. $PFE
2 Companies Poised to Capitalize on the Rise of GLP-1 Weight Loss Drugs | Morningstar
Ossiam Purchases 2,349,058 Shares of Pfizer Inc. $PFE - Daily Political
Five years of COVID vaccines: how a breakthrough created a public-heath crisis
Eli Lilly, Pfizer, Johnson secure spots on China's drug catalog, Bloomberg says | Markets Insider
Scott Gottlieb says Hepatitis B vaccine birth dose prevents chronic infection - CBS News
Pfizer presents results from the Phase 3 BASIS study on HYMPAVZI | Markets Insider
Transcript: Scott Gottlieb on "Face the Nation with Margaret Brennan," Dec. 7, 2025 - CBS News
Federated Hermes Inc. Raises Stock Position in Pfizer Inc. $PFE
Brown Advisory Inc. Lowers Holdings in Pfizer Inc. $PFE
Pfizer (NYSE:PFE) Shares Up 1.3% - What's Next? - Stock Observer
Eli Lilly, Pfizer Land on China's First Private Insurance List
Kennedy Capital Management LLC Decreases Holdings in Pfizer Inc. $PFE - Daily Political
Findings from the Phase 3 study were presented at the 67 th
HYMPAVZI® (marstacimab) Reduced Bleeds by 93% Compared to On-Demand Treatment in Adults and Adolescents with Hemophilia A or B with Inhibitors
Pharmaceutical Stocks To Watch Today - December 6th - Markets Daily
Experts fear for US childhood vaccine schedule after hepatitis B guideline change - Yahoo News Canada
Cresset Asset Management LLC Boosts Stake in Pfizer Inc. $PFE
Can Pfizer's Recent Recovery Signal a Long Term Value Opportunity in 2025?
Pfizer Inc. $PFE Holdings Lowered by Panagora Asset Management Inc. - Daily Political
Exclusive | AI giant Anthropic hires ex-Chuck Schumer, Eric Adams staffer amid 'woke' claims | New York Post
Immunotherapy Drugs Research Report 2025: $526.5 Bn Market Opportunities, Growth Drivers, Industry Trend Analysis, and Forecast 2024-2034
'DNA contamination in Pfizer': Bombshell testimony 'exposes' COVID-vaccine 'lies' at Senate hearing - The Economic Times Video | ET Now
First long-term study on COVID deaths suggests vaccines safe four years on
Baird Financial Group Inc. Sells 406,942 Shares of Pfizer Inc. $PFE
Pfizer Inc. (PFE): A Bull Case Theory
US Acute Myeloid Leukemia Market Size & Share Forecast 2025-2033 | Taiwan News | Dec. 5, 2025 10:13
Personalized ctDNA detection and genomic profiling in the NeoRHEA Study
Immunologic and biophysical features of the BNT162b2 JN.1 and KP.2 adapted COVID-19 vaccines
